Capricor Therapeutics
(NASDAQ) CAPR
Capricor Therapeutics Financials at a Glance
Market Cap
$1.85B
Revenue (TTM)
$0.00
Net Income (TTM)
$105.04M
EPS (TTM)
$-2.26
P/E Ratio
-14.23
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Price
$32.10
Volume
59,111
Open
$29.09
Price
$32.10
Volume
59,111
Open
$29.09
Previous Close
$32.10
Daily Range
$29.09 - $32.29
52-Week Range
$4.30 - $40.37
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Price
$32.10
Volume
59,111
Open
$29.09
Previous Close
$32.10
Daily Range
$29.09 - $32.29
52-Week Range
$4.30 - $40.37
CAPR News
CAPR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Capricor Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
231
CEO
Linda Marbán, PhD
Website
www.capricor.comHeadquarters
San Diego, CA 92121, US
CAPR Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-47%
Return on Capital
-34%
Return on Assets
-30%
Earnings Yield
-7.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.85B
Shares Outstanding
57.51M
Volume
59.11K
Short Interest
0.00%
Avg. Volume
1.39M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$108.14M
EBITDA
$108.14M
Operating Cash Flow
$69.81B
Capital Expenditure
$2.90B
Free Cash Flow
$72.72B
Cash & ST Invst.
$318.13M
Total Debt
$20.94M
Capricor Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$1.85B
N/A
Market Cap/Employee
$11.54M
N/A
Employees
160
N/A
Net Income
$30.17M
-324.0%
EBITDA
$29.16M
-298.2%
Quarterly Fundamentals
Net Cash
$297.18M
+98.0%
Accounts Receivable
$59.17K
-99.4%
Inventory
$0.00
N/A
Long Term Debt
$14.32M
+2223.6%
Short Term Debt
$6.62M
+693.5%
Return on Assets
-29.51%
N/A
Return on Invested Capital
-33.78%
N/A
Free Cash Flow
$28.69M
-84.7%
Operating Cash Flow
$23.57M
-59.3%